1. Please check and comment entries here.
Table of Contents

    Topic review

    ARID1B Gene

    View times: 12
    Submitted by: Vicky Zhou
    (This entry belongs to Entry Collection "MedlinePlus ")

    Definition

    AT-rich interaction domain 1B

    1. Normal Function

    The ARID1B gene provides instructions for making a protein that forms one piece (subunit) of several different SWI/SNF protein complexes. SWI/SNF complexes regulate gene activity (expression) by a process known as chromatin remodeling. Chromatin is the network of DNA and proteins that packages DNA into chromosomes. The structure of chromatin can be changed (remodeled) to alter how tightly DNA is packaged. Chromatin remodeling is one way gene expression is regulated during development; when DNA is tightly packed, gene expression is lower than when DNA is loosely packed.

    Through their ability to regulate gene activity, SWI/SNF complexes are involved in many processes, including repairing damaged DNA; copying (replicating) DNA; and controlling the growth, division, and maturation (differentiation) of cells. The ARID1B protein and other SWI/SNF subunits are thought to act as tumor suppressors, which keep cells from growing and dividing too rapidly or in an uncontrolled way.

    The ARID1B subunit is able to attach (bind) to DNA and is thought to help target SWI/SNF complexes to the chromatin location that needs to be remodeled.

    2. Health Conditions Related to Genetic Changes

    2.1. Coffin-Siris Syndrome

    At least 69 mutations in the ARID1B gene have been found to cause Coffin-Siris syndrome. This condition is characterized by delayed development, abnormalities of the fifth (pinky) fingers or toes, and characteristic facial features that are described as coarse. Most ARID1B gene mutations involved in Coffin-Siris syndrome lead to an abnormally short, nonfunctional protein. As a result, affected individuals have half the normal amount of functional ARID1B protein. Although it is unclear how these changes affect SWI/SNF complexes, researchers suggest that ARID1B gene mutations result in abnormal chromatin remodeling. Disturbance of this process alters the activity of many genes and disrupts several cellular processes, which could explain the diverse signs and symptoms of Coffin-Siris syndrome. People with Coffin-Siris syndrome do not appear to have an increased risk of cancer (see below).

    2.2. Autism Spectrum Disorder

    At least 13 ARID1B gene mutations have been identified in people with autism spectrum disorder (ASD), a varied condition characterized by impaired social skills, communication problems, and repetitive behaviors. Some affected individuals also have other features, including intellectual disability, severe speech problems, and brain malformations. The ARID1B gene mutations associated with ASD result in a reduced amount of the ARID1B protein or impair the protein's function in chromatin remodeling. These changes likely affect the control of gene expression and interfere with normal brain development, but the specific relationship between the mutations and ASD is unknown.

    2.3. Other Disorders

    Mutations in the ARID1B gene can cause intellectual disability without other hallmark features of Coffin-Siris syndrome (described above). As in Coffin-Siris syndrome, the gene mutations that cause intellectual disability lead to an abnormally short, nonfunctional protein, and affected individuals have half the normal amount of ARID1B protein. It is unclear why some people with an ARID1B gene mutation develop intellectual disability and others have the additional features of Coffin-Siris syndrome.

    2.4. Cancers

    Mutations in the ARID1B gene are involved in several types of cancer, including breast cancer, a childhood cancer of nerve tissue called neuroblastoma, and a type of blood cancer called diffuse large B-cell lymphoma. These mutations are somatic, which means they are acquired during a person's lifetime and are present only in tumor cells. The mechanism by which mutations in the ARID1B gene contribute to cancer is unknown, although it is thought that changes in SWI/SNF complexes are involved. These changes may impair normal cell differentiation, which leads to the overgrowth of certain cell types, causing cancer. Alternatively, abnormal SWI/SNF complexes may disrupt the regulation of genes that help control the growth and division of cells, which leads to cancer. It is likely that other genetic changes in addition to ARID1B gene mutations are necessary for cancer development.

    3. Other Names for This Gene

    • 6A3-5
    • ARI1B_HUMAN
    • ARID domain-containing protein 1B
    • AT rich interactive domain 1B (SWI1-like)
    • AT-rich interactive domain-containing protein 1B
    • BAF250B
    • BRG1-associated factor 250b
    • BRG1-binding protein ELD/OSA1
    • BRIGHT
    • DAN15
    • ELD (eyelid)/OSA protein
    • ELD/OSA1
    • KIAA1235
    • MRD12
    • OSA2
    • P250R

    The entry is from https://medlineplus.gov/genetics/gene/arid1b

    References

    1. D'Gama AM, Pochareddy S, Li M, Jamuar SS, Reiff RE, Lam AN, Sestan N, WalshCA. Targeted DNA Sequencing from Autism Spectrum Disorder Brains ImplicatesMultiple Genetic Mechanisms. Neuron. 2015 Dec 2;88(5):910-917. doi:10.1016/j.neuron.2015.11.009.
    2. Halgren C, Kjaergaard S, Bak M, Hansen C, El-Schich Z, Anderson CM, Henriksen KF, Hjalgrim H, Kirchhoff M, Bijlsma EK, Nielsen M, den Hollander NS, Ruivenkamp CA, Isidor B, Le Caignec C, Zannolli R, Mucciolo M, Renieri A, Mari F, AnderlidBM, Andrieux J, Dieux A, Tommerup N, Bache I. Corpus callosum abnormalities,intellectual disability, speech impairment, and autism in patients withhaploinsufficiency of ARID1B. Clin Genet. 2012 Sep;82(3):248-55. doi:10.1111/j.1399-0004.2011.01755.x.
    3. Hoyer J, Ekici AB, Endele S, Popp B, Zweier C, Wiesener A, Wohlleber E, Dufke A, Rossier E, Petsch C, Zweier M, Göhring I, Zink AM, Rappold G, Schröck E,Wieczorek D, Riess O, Engels H, Rauch A, Reis A. Haploinsufficiency of ARID1B, a member of the SWI/SNF-a chromatin-remodeling complex, is a frequent cause ofintellectual disability. Am J Hum Genet. 2012 Mar 9;90(3):565-72. doi:10.1016/j.ajhg.2012.02.007.
    4. Nord AS, Roeb W, Dickel DE, Walsh T, Kusenda M, O'Connor KL, Malhotra D,McCarthy SE, Stray SM, Taylor SM, Sebat J; STAART Psychopharmacology Network,King B, King MC, McClellan JM. Reduced transcript expression of genes affected byinherited and de novo CNVs in autism. Eur J Hum Genet. 2011 Jun;19(6):727-31.doi: 10.1038/ejhg.2011.24.
    5. Santen GW, Aten E, Sun Y, Almomani R, Gilissen C, Nielsen M, Kant SG, SnoeckIN, Peeters EA, Hilhorst-Hofstee Y, Wessels MW, den Hollander NS, Ruivenkamp CA, van Ommen GJ, Breuning MH, den Dunnen JT, van Haeringen A, Kriek M. Mutations in SWI/SNF chromatin remodeling complex gene ARID1B cause Coffin-Siris syndrome. NatGenet. 2012 Mar 18;44(4):379-80. doi: 10.1038/ng.2217.
    6. Santen GW, Kriek M, van Attikum H. SWI/SNF complex in disorder: SWItching frommalignancies to intellectual disability. Epigenetics. 2012 Nov;7(11):1219-24.doi: 10.4161/epi.22299.
    7. Shain AH, Pollack JR. The spectrum of SWI/SNF mutations, ubiquitous in humancancers. PLoS One. 2013;8(1):e55119. doi: 10.1371/journal.pone.0055119.
    8. Tsurusaki Y, Okamoto N, Ohashi H, Kosho T, Imai Y, Hibi-Ko Y, Kaname T,Naritomi K, Kawame H, Wakui K, Fukushima Y, Homma T, Kato M, Hiraki Y, YamagataT, Yano S, Mizuno S, Sakazume S, Ishii T, Nagai T, Shiina M, Ogata K, Ohta T,Niikawa N, Miyatake S, Okada I, Mizuguchi T, Doi H, Saitsu H, Miyake N, MatsumotoN. Mutations affecting components of the SWI/SNF complex cause Coffin-Sirissyndrome. Nat Genet. 2012 Mar 18;44(4):376-8. doi: 10.1038/ng.2219.
    9. Wang X, Nagl NG, Wilsker D, Van Scoy M, Pacchione S, Yaciuk P, Dallas PB,Moran E. Two related ARID family proteins are alternative subunits of humanSWI/SNF complexes. Biochem J. 2004 Oct 15;383(Pt 2):319-25.
    More

    Keywords